Review: anti CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Works matching IS 10837159 AND DT 2007 AND VI 12 AND IP 7
Results: 15
1
2
Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
3
Tremelimumab (CP-675,206), a Cytotoxic T Lymphocyte Associated Antigen 4 Blocking Monoclonal Antibody in Clinical Development for Patients with Cancer.
- Published in:
- Oncologist, 2007, v. 12, n. 7, p. 873, doi. 10.1634/theoncologist.12-7-873
- Publication type:
- Article
4
Delays in Cancer Diagnosis in Underinsured Young Adults and Older Adolescents.
- Published in:
- Oncologist, 2007, v. 12, n. 7, p. 816, doi. 10.1634/theoncologist.12-7-816
- Publication type:
- Article
5
Commentary: A Case of Minimizing Folate Supplementation in Clinical Regimens with Pemetrexed Based on the Marked Sensitivity of the Drug to Folate Availability.
- Published in:
- Oncologist, 2007, v. 12, n. 7, p. 808, doi. 10.1634/theoncologist.12-7-808
- Publication type:
- Article
6
Some Aspects of the Endocrine Profile and Management of Hormone-Dependent Male Breast Cancer.
- Published in:
- Oncologist, 2007, v. 12, n. 7, p. 798, doi. 10.1634/theoncologist.12-7-798
- Publication type:
- Article
7
Fulvestrant (Faslodex®)--How to Make a Good Drug Better.
- Published in:
- Oncologist, 2007, v. 12, n. 7, p. 774, doi. 10.1634/theoncologist.12-7-774
- Publication type:
- Article
8
Central Nervous System Metastases in HER-2-Positive Metastatic Breast Cancer Patients Treated with Trastuzumab: Incidence, Survival, and Risk Factors.
- Published in:
- Oncologist, 2007, v. 12, n. 7, p. 766, doi. 10.1634/theoncologist.12-7-766
- Publication type:
- Article
9
Erlotinib in Non-Cell Lung Cancer Treatment: Current Status and Future Development.
- Published in:
- Oncologist, 2007, v. 12, n. 7, p. 840, doi. 10.1634/theoncologist.12-7-840
- Publication type:
- Article
10
Multidisciplinary Management of Brain Metastases.
- Published in:
- Oncologist, 2007, v. 12, n. 7, p. 884, doi. 10.1634/theoncologist.12-7-884
- By:
- Publication type:
- Article
11
Review: Anti-CTLA-4 Antibody Ipilimumab: Case Studies of Clinical Response and Immune-Related Adverse Events.
- Published in:
- Oncologist, 2007, v. 12, n. 7, p. 864, doi. 10.1634/theoncologist.12-7-864
- By:
- Publication type:
- Article
12
Multidisciplinary Treatment of Malignant Pleural Mesothelioma.
- Published in:
- Oncologist, 2007, v. 12, n. 7, p. 850, doi. 10.1634/theoncologist.12-7-850
- By:
- Publication type:
- Article
13
Presurgical Chemotherapy in Patients Being Considered for Liver Resection.
- Published in:
- Oncologist, 2007, v. 12, n. 7, p. 825, doi. 10.1634/theoncologist.12-7-825
- By:
- Publication type:
- Article
14
First-Line Treatment Options for Patients with HER-2-Negative Metastatic Breast Cancer: The Impact of Modern Adjuvant Chemotherapy.
- Published in:
- Oncologist, 2007, v. 12, n. 7, p. 785, doi. 10.1634/theoncologist.12-7-785
- By:
- Publication type:
- Article
15
Lapatinib-Associated Toxicity and Practical Management Recommendations.
- Published in:
- Oncologist, 2007, v. 12, n. 7, p. 756, doi. 10.1634/theoncologist.12-7-756
- By:
- Publication type:
- Article